Join the IMAC team, including Medical Director Nikki Turner and Medical Advisor and GP Dr Mamaeroa David on the topic of maternal immunisations.

New video resource for Shingrix vaccine preparation

Join our informative Vaccinating Health Worker (VHW) drop-in sessions each fortnight for support, information sharing, and to address questions related to the VHW workforce and the training pathway

Bexsero reminder: catchup and scheduled vaccines for under 5s

Boostrix clarification for doses for 45- and 65-year-olds.

Two new IMAC online courses are now available - for COVID-19, and midwife vaccinators

Please ensure your stock is checked for expired vaccines

Our 0800IMMUNE Saturday Service has ended – with our Monday-Friday service continuing as normal, operating from 8.30am-5pm each weekday.

View IMAC’s latest webinar for pharmacist vaccinators, which covers clinical information and scope to support the delivery of the extended range of funded vaccines in pharmacies

Effective engagement for immunisation of pēpi Māori in primary care

See the latest version of the Immunisation Handbook on the Manatū Hauora website

Auckland Regional Public Health Service has ordered Auckland's Albany Senior High School to temporarily close under the Health Act while health authorities investigate a potential measles case.

Keeping it cool - a webinar to refresh your Cold Chain knowledge

Loretta Roberts, National Director of the Immunisation Advisory Centre (IMAC) responds to the Immunisation Taskforce report Initial Priorities for the National Immunisation Programme in Aotearoa (the report).

An update on Boosters

Pertussis vaccinations are free and so important for hapū mama and young children.

This course was a temporary pathway for eligible and interested provisionally authorised vaccinators to become fully authorised vaccinators.

Measles is here so you'll need to access our resources.

Quick answers to key questions

Measles is highly infectious and causes severe illness but vaccination is easy and free.

Comirnaty (3mcg) 6m-4y maroon cap vaccine is now available for children at high risk of COVID.

Bexsero, MenB vaccine is to be funded from 1 March 2023

Body of evidence shows bivalent COVID booster is better than mono.

Vaccination has been found to reduce preterm birth, low birth weight and stillbirth in a New Zealand study published and promoted by the highly reputable Centre for Disease Control today.

The Vaccinating Health Worker Stage 1 Training is now available for enrolment. Please see here for more information.

A position paper from the Immunisation Advisory Centre: Professor (Hon) Nikki Turner, Professor Peter McIntyre, Dr Joan Ingram, Dr Emma Best, Dr Edwin Reynolds, Dr Liz Wilson.

MenB (Bexsero) will be funded for immunisations from 1 March 2023.

If you wish to become a fully authorised vaccinator after the closing of the Provisional Vaccinator Update Course or your Provisional Authorised Vaccinator certificate has expired, you can become part of the immunisation workforce via the Vaccinator Foundation Course pathway.

The mpox vaccine continues to be available in New Zealand. Administration method has now changed to 'subcutaneous administration only'. People who are concerned they may have or are at risk of exposure to mpox, should complete an initial assessment on: https://www.burnettfoundation.org.nz or call the mpox Healthline: 0800 116 672 (between 8am and 8pm).

Child immunisations have dropped so far during COVID that the World Health Organisation and UNICEF are raising the alarm, as is the Immunisation Advisory Centre, IMAC. Internationally 25 million children have missed out on life-saving vaccinations and here in New Zealand Aotearoa we are seeing a similarly concerning trend

All authorised vaccinators are required to attend an update course every two years. Some Provisional Authorised Vaccinators are approaching two years since they completed their Provisional Vaccinator Foundation Course in 2020 and due to an administrative change their authorisation does not expire until 2023.

All the vaccines on the National Immunisation Schedule can now be given concurrently, immediately before or after the mRNA-COVID-19 vaccine, Comirnaty, with the exception of the shingles vaccine (Zostavax). This includes MMR, influenza, HPV (Gardasil 9), tetanus, diphtheria and pertussis (Boostrix) and the meningococcal vaccines (Bexsero and Menactra).